Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor

NCT00356525 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

INDUSTRY

Sponsor class

Stopped Stopped early due to low enrollment

Conditions

Lung Neoplasms

Interventions

DRUG: pemetrexed
DRUG: gemcitabine
DRUG: carboplatin
DRUG: Pemetrexed

Sponsor

Eli Lilly and Company